RSSPsychiatry

Measurement-based Care in Psychiatry— Past, Present, and Future

Measurement-based Care in Psychiatry— Past, Present, and Future

| November 1, 2018

by Ahmed Aboraya, MD, Dr.PH; Henry A. Nasrallah, MD; Daniel E. Elswick, MD; Ahmed Elshazly, MD; Nevine Estephan, MD; Dalia Aboraya, BA; Seher Berzingi; Josleen Chumbers; Aara Berzingi, BA; John Justice, MD; Jawad Zafar, DO; and Sheena Dohar, MD Dr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry […]

Continue Reading

Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs

Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs

| November 1, 2018

By Adegboyega Oyemade, MD, FAPA Funding/financial disclosures. The author has no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2018;15(11–12):11–12 Dear Editor: Fentanyl was created in 1960 as an intravenous surgical anesthetic (Sublimaze®, Janssen Pharmaceuticals Inc.), which is 50 to 100 […]

Continue Reading

The Assessment and Measurement of Wellness in the Clinical Medical Setting: A Systematic Review

The Assessment and Measurement of Wellness in the Clinical Medical Setting: A Systematic Review

| October 1, 2018

Continue Reading

Risk Management: My Patient Suicided, Now What?

Risk Management: My Patient Suicided, Now What?

| October 1, 2018

Continue Reading

The Neuroscience Report—Vol. 53 (August 14, 2018): Binge Eating Disorders

The Neuroscience Report—Vol. 53 (August 14, 2018): Binge Eating Disorders

| August 14, 2018 | 0 Comments

Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information.   This week’s topic: Binge Eating Disorder   5 Journal Articles Binge eating, trauma, and suicide attempt in community […]

Continue Reading

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

| July 1, 2018 | 0 Comments

Continue Reading

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

| May 1, 2018 | 0 Comments

by David V. Sheehan, MD, MBA; Maria Gasior, MD, PhD; Susan L. McElroy, MD; Jana Radewonuk, MSc; Barry K. Herman, MD, MMM; and James Hudson, MD, ScD Dr. Sheehan is with the University of South Florida College of Medicine in Tampa, Florida. Drs. Herman and Gasior and Ms. Radewonuk are formerly affiliated with Shire Pharmaceuticals […]

Continue Reading